These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27409525)

  • 1. Patients with retinoblastoma and chromosome 13q deletions have increased chemotherapy-related toxicities.
    Brennan RC; Qaddoumi I; Billups CA; Kaluzny T; Furman WL; Wilson MW
    Pediatr Blood Cancer; 2016 Nov; 63(11):1954-8. PubMed ID: 27409525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.
    Cobbs LV; Francis JH; Dunkel IJ; Gobin YP; Brodie SE; Abramson DH
    Pediatr Blood Cancer; 2021 May; 68(5):e28845. PubMed ID: 33355996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic risk-based adjuvant chemotherapy for unilateral retinoblastoma following enucleation.
    Sullivan EM; Wilson MW; Billups CA; Wu J; Merchant TE; Brennan RC; Haik BG; Shulkin B; Free TM; Given V; Rodriguez-Galindo C; Qaddoumi I
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e335-40. PubMed ID: 24577551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.
    Brennan RC; Qaddoumi I; Mao S; Wu J; Billups CA; Stewart CF; Hoehn ME; Rodriguez-Galindo C; Wilson MW
    J Clin Oncol; 2017 Jan; 35(1):72-77. PubMed ID: 28034080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
    Qaddoumi I; Billups CA; Tagen M; Stewart CF; Wu J; Helton K; McCarville MB; Merchant TE; Brennan R; Free TM; Given V; Haik BG; Rodriguez-Galindo C; Wilson MW
    Cancer; 2012 Nov; 118(22):5663-70. PubMed ID: 22516936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL; Himelstein B; Shields CL; Shields JA; Needle M; Miller D; Bunin GR; Meadows AT
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
    Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
    Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
    J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
    Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
    Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial deletion of 13q and a 13;X chromosome translocation results in partial trisomy 13 and bilateral retinoblastoma.
    Dries D; Baca K; Truss L; Dobin S
    Ophthalmic Genet; 2003 Sep; 24(3):175-80. PubMed ID: 12868036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome.
    El Hamichi S; Acon D; Kon Graversen V; Gold AS; Berrocal AM; Murray TG
    Pediatr Neurosurg; 2020; 55(5):295-298. PubMed ID: 33176321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
    Kim JH; Yu YS; Khwarg SI; Choi HS; Shin HY; Ahn HS
    Korean J Ophthalmol; 2003 Jun; 17(1):35-43. PubMed ID: 12882506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.